Marcel Doerflinger
Kingsbury Drive
Bundoora, VIC 3086, Australia
Bundoora, VIC 3086, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease.
Journal: EBioMedicine
Published: February 23, 2026
Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation.
Journal: Nature communications
Published: January 04, 2026
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors.
Journal: Science advances
Published: July 09, 2025
Lipid nanoparticle-delivered intrabodies for inhibiting necroptosis and pyroptosis.
Journal: The Biochemical journal
Published: May 07, 2025
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4+ T cells.
Journal: Nature communications
Published: April 29, 2025
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia.
Journal: Clinical & translational immunology
Published: February 19, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.
Journal: Nature communications
Published: December 18, 2024
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection.
Journal: Nature communications
Published: November 13, 2024
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.
Journal: Wellcome open research
Published: October 10, 2024
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.
Journal: Cell death and differentiation
Published: July 30, 2024
Last Updated: 09/26/2026